These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28691689)

  • 41. Immunoglobulin-induced aseptic meningitis: a case report.
    Graça L; Alves J; Nuak J; Sarmento A
    BMC Neurol; 2018 Jul; 18(1):97. PubMed ID: 30016937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
    Yanes DA; Mosser-Goldfarb JL
    Pediatr Dermatol; 2017 Jan; 34(1):e30-e31. PubMed ID: 27813209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients.
    Böckle BC; Sepp NT
    Lupus; 2015 Jun; 24(7):669-74. PubMed ID: 25411260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Widespread Scaly Eruption in a Patient With Multiple Comorbidities.
    Jones EK; Mingioni N; Lee JB
    JAMA; 2015 Oct; 314(16):1740-1. PubMed ID: 26505598
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug-induced lupus erythematosus.
    Antonov D; Kazandjieva J; Etugov D; Gospodinov D; Tsankov N
    Clin Dermatol; 2004; 22(2):157-66. PubMed ID: 15234017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symmetric distribution of lupus erythematosus tumidus on the elbows.
    Di Cesare A; Fargnoli MC; Lozzi GP; Peris K
    Eur J Dermatol; 2006; 16(4):450-1. PubMed ID: 16935815
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
    Wong NY; Parsons LM; Trotter MJ; Tsang RY
    BMC Res Notes; 2014 Nov; 7():785. PubMed ID: 25369825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
    Abbott RA; May K; Motley RJ
    Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Kerr OA; Murray CS; Tidman MJ
    Clin Exp Dermatol; 2004 May; 29(3):319-20. PubMed ID: 15115526
    [No Abstract]   [Full Text] [Related]  

  • 51. An unusual clinical presentation of lupus erythematosus tumidus localized on the thigh.
    Hashimoto T; Kawakami Y; Wakabayashi H; Oda W; Hamada T; Doi H; Aoyama Y; Iwatsuki K
    Clin Exp Dermatol; 2017 Aug; 42(6):638-641. PubMed ID: 28597962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 53. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
    Nutan F; Ortega-Loayza AG
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus.
    Hügel R; Schwarz T; Gläser R
    Br J Dermatol; 2007 Nov; 157(5):1081-3. PubMed ID: 17854374
    [No Abstract]   [Full Text] [Related]  

  • 55. Golimumab-exacerbated subacute cutaneous lupus erythematosus.
    Wilkerson E; Hazey MA; Bahrami S; Callen JP
    Arch Dermatol; 2012 Oct; 148(10):1186-90. PubMed ID: 23069957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subacute cutaneous lupus erythematosus associated with terbinafine.
    Kasperkiewicz M; Anemüller W; Angelova-Fischer I; Rose C; Zillikens D; Fischer TW
    Clin Exp Dermatol; 2009 Oct; 34(7):e403-4. PubMed ID: 19549237
    [No Abstract]   [Full Text] [Related]  

  • 57. The first case of natalizumab-induced subacute cutaenous lupus erythematosus.
    Bolton C; Mouyis K; Bhamra K; Steuer A
    Rheumatology (Oxford); 2020 Jun; 59(6):1446-1447. PubMed ID: 31638704
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
    Tanaka Y; Takeuchi T; Miyasaka N; Sumida T; Mimori T; Koike T; Endo K; Mashino N; Yamamoto K
    Mod Rheumatol; 2016; 26(1):80-6. PubMed ID: 26054418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diltiazem and subacute cutaneous lupus erythematosus-like lesions.
    Crowson AN; Magro CM
    N Engl J Med; 1995 Nov; 333(21):1429. PubMed ID: 7477141
    [No Abstract]   [Full Text] [Related]  

  • 60. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
    Cookson H; Walsh S
    Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.